Skip to main content

Alendronic Acid Tablets

Type of Posting: Revision Bulletin*: POSTPONEMENT

Posting Date: 14–Jun–2006

In accordance with Section 9.06(c) of the Rules and Procedures of the Council of Experts, the USP Nomenclature Expert Committee has postponed the official date of the title for this new monograph, which was published on page 64 of USP 28–NF 23, from July 1, 2006, until May 1, 2008. The postponement is intended to provide additional time for product label changes to be completed and for healthcare practitioners and consumers to become familiar with the terminology. Use of this title has been permitted since January 1, 2005, when the monograph first became official, but will not become mandatory until May 1, 2008, the official date of USP 31–NF 26.

The Salt Nomenclature Policy, on which this monograph title is based, is being published in the July–August 2006 issue of Pharmacopeial Forum as part of the revised general information chapter Nomenclature <1121> for public review and comment.

Should you have any questions, please contact Dr. W. Larry Paul, Scientific Fellow and Scientific Liaison to the Nomenclature Expert Committee at +1-301-816-8331 or wlp@usp.org.

*In accordance with Section 9.01 of the Rules and Procedures of the Council of Experts, a Revision Bulletin is an official publication of the United States Pharmacopeia and the National Formulary. The Revision Bulletin, which is posted on USP's website and sent to affected manufacturers via mail and e-mail, is being used in this case due to the need to make the postponement effective immediately given the impending official date. The postponement also will appear in the Fifth IRA (in PF 32(5)) to USP 29–NF 24. This postponement has been approved by the Nomenclature Expert Committee and Chair of the Council of Experts in accordance with Section 9.06(c) of the Rules and Procedures of the Council of Experts.